ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $650,211 | -12.3% | 59,380 | +6.0% | 0.00% | -50.0% |
Q2 2023 | $741,361 | -69.2% | 55,994 | -68.3% | 0.00% | -60.0% |
Q1 2023 | $2,406,547 | -39.1% | 176,822 | -12.6% | 0.01% | -44.4% |
Q4 2022 | $3,951,759 | -42.5% | 202,343 | -43.9% | 0.01% | -47.1% |
Q3 2022 | $6,875,000 | -25.0% | 360,881 | -18.9% | 0.02% | -19.0% |
Q2 2022 | $9,169,000 | +141.3% | 445,110 | +276.9% | 0.02% | +200.0% |
Q1 2022 | $3,800,000 | – | 118,085 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |